Tyrosine Kinase Inhibitors for Acute Respiratory Failure Because of Non–small-Cell Lung Cancer Involvement in the ICU-Reference-Cited by-同舟云学术

Tyrosine Kinase Inhibitors for Acute Respiratory Failure Because of Non–small-Cell Lung Cancer Involvement in the ICU

Published:2022-01 Issue:1 Volume:161 Page:284-287
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Tandjaoui-Lambiotte Yacine,Akrour Yanis,Gibelin Aude,Gonzalez Frederic,Stoclin Annabelle,Moreau Anne-Sophie,Jaubert Paul,Oppenheimer Anne,Duchemann Boris,Gaudry Stéphane

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference10 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Lung cancer at the intensive care unit: the era of targeted therapy;Adam;Lung Cancer,2015

3. Characteristics and outcome of patients with newly diagnosed advanced or metastatic lung cancer admitted to intensive care units (ICUs);Barth;Ann Intensive Care,2018

4. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries;Allemani;Lancet,2018

5. Treatment of lung cancer patients with actionable mutations in the intensive care unit;Kerrigan;Clin Lung Cancer,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complications sévères des traitements systémiques du patient cancéreux thoracique (complications hors infections et urgences respiratoires);Revue des Maladies Respiratoires;2024-04

2. To Crush or Not to Crush: Administering Dabrafenib and Trametinib Through a Nasogastric Tube in a Critically Ill Patient With Nonsmall Cell Lung Cancer – A Case Report and Review of Literature of Targeted Therapies Given Through Enteral Feeding Tubes;Clinical Lung Cancer;2023-12

3. Scalable Production and In Vitro Efficacy of Inhaled Erlotinib Nanoemulsion for Enhanced Efficacy in Non-Small Cell Lung Cancer (NSCLC);Pharmaceutics;2023-03-20

4. Prognostic factors for advanced lung cancer patients with do-not-intubate order in intensive care unit: a retrospective study;BMC Pulmonary Medicine;2022-06-24

5. Patterns of ICU admissions and outcomes in patients with solid malignancies over the revolution of cancer treatment;Annals of Intensive Care;2021-12